Cosmos Health Signs LOI to Acquire Doc Pharma S.A., a European GMP Pharmaceutical Manufacturer, a Transformative Step Expected to Boost Assets, Profitability, Production Capacity, and Product Portfolio
Cosmos Health Inc. (NASDAQ:COSM) has signed a non-binding letter of intent to acquire 100% of Doc Pharma S.A., a European GMP-certified pharmaceutical manufacturer with a $24M asset base and diverse production capabilities. The acquisition aims to deepen vertical integration, expand production capacity, enhance the product portfolio with advanced a…